Levocarnitine Impurity 2 | CAS 226213-72-5 - Request Quote
Levocarnitine Impurity 2
| SZ CAT No: | SZ-L040010 |
| CAS No | 226213-72-5 |
| Mol.F. | C4H8ClNO2 |
| Mol.Wt. | 137.6 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Levocarnitine Impurity 2 is chemically (R)-4-Chloro-3-hydroxybutanamide. Levocarnitine Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Levocarnitine Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levocarnitine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 226213-72-5
Purchase 226213-72-5
Order 226213-72-5
Enquire 226213-72-5
price of 226213-72-5
226213-72-5 Supplier
226213-72-5 Manufacturer
226213-72-5 Exporter
buy high quality Levocarnitine Impurity 2
Purchase Levocarnitine Impurity 2
Levocarnitine Impurity 2 suppliers
Levocarnitine Impurity 2 manufacturers
Levocarnitine Impurity 2 price
Order Levocarnitine Impurity 2
Enquire Levocarnitine Impurity 2
Levocarnitine Impurity 2 cost
Levocarnitine Impurity 2 Supplier
Levocarnitine Impurity 2 Distributor
Levocarnitine Impurity 2 for Method Validation
Levocarnitine Reference Standard
Levocarnitine Impurity 2 for ANDA Filing
Levocarnitine Impurity 2 for Forced Degradation Studies
Levocarnitine Impurity 2 Identification Standards
Levocarnitine Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.